Articles related to Psychiatry

The FDA-approved Rejoyn app, designed for major depressive disorder, combines therapeutic exercises and emotional regulation training to complement antidepressant therapy, showing significant improvement in clinical trials.

HHS is offering a new funding opportunity to advance AI in healthcare and improve health IT in behavioral health settings. The initiative focuses on developing scalable methods to enhance EHR data quality for AI tools and accelerating health IT capabilities in behavioral health.

Recent studies indicate that while ketamine and ECT are equally effective for treating MDD, ketamine did not prove non-inferior to ECT for MDEs. Both treatments have distinct side effect profiles that are critical for clinical decision-making.

Research presented at the APA 2024 Annual Meeting sheds light on innovative treatments and the multifaceted burden of anxiety disorders, highlighting significant advances in managing GAD and related comorbidities.

The Medscape Women Physicians Report 2020 reveals that 64% of female physicians prioritize work-life balance, often feeling conflicted between their careers and caregiving responsibilities, necessitating flexible work arrangements and supportive policies.

Recent research indicates an incremental risk of cardiomyopathy associated with extended stimulant use in ADHD treatment among young adults. Notably, this risk peaks at eight years of therapy, reinforcing the need for vigilant cardiovascular monitoring.